Jan 31 2025

RFK Jr. Says He Will Defer to DEA on Marijuana Rescheduling if Confirmed as HHS Secretary

RFK Jr. says he will leave the decision on marijuana rescheduling to the Drug Enforcement Administration (DEA) if confirmed as secretary of HHS.

When asked by Elizabeth Warren (D)  “Do you commit to working with the DOJ and DEA to swiftly resume proceedings on the scheduling of marijuana (which are currently paused)?”

RFK Jr. responded: “I defer to the DOJ and DEA on the allocation of their resources and the development of their priorities. Consistent with all applicable laws, I will ensure that HHS’s expertise is available to assist those agencies as needed.” He goes on to say that “if an assessment backed by robust evidence concludes that marijuana has accepted medical uses, I have no reason to question that assessment.”
Continue reading

Jan 31 2025

Montana Committee Overwhelmingly Approves Resolution Endorsing Federal SAFER Banking Act

A resolution urging the federal government to approve marijuana banking legislation has been approved by the Montana’s Senate Business, Labor, and Economic Affairs Committee.

Senate Joint Resolution 5 was approved by the committee today by a vote of 9 to 2, indicating strong bipartisan support.

The resolution urges federal lawmakers to pass the SAFER Banking Act, which would allow banks and other financial institutions to serve state-legal marijuana businesses, enabling these businesses to move away from a risky cash-only model. The measure would also grant them access to banking services such as lines of credit and allow them to claim standard IRS tax deductions.
Continue reading

Jan 31 2025

Connecticut Lawmakers to Hold Public Hearing on Minimum Wage Rules for Marijuana Industry Workers

House Bill 6842, which would ensure that employees at cannabis establishments receive at least the state’s minimum fair wage, has been scheduled for a public hearing on February 6 in the Joint Committee on Labor and Public Employees.

The bill, introduced in the Connecticut House of Representatives by the chair of the House Labor and Public Employees Committee, clarifies that cannabis industry employees must be paid the full minimum wage and that employers cannot count gratuities toward that wage. While some industries, such as restaurants and hospitality, are allowed to apply tips toward meeting minimum wage requirements, HB 6842 explicitly prevents marijuana businesses from doing the same.

The legislation states that “nothing in this section, or any regulation adopted pursuant to this section, shall be construed to require the Labor Commissioner to recognize, as part of the minimum fair wage, gratuities in an amount equal to the difference between the minimum fair wage and the employer’s share for persons who are employed at a cannabis establishment.” It defines “cannabis establishment” based on the existing legal definition in Section 21a-420 of Connecticut law.
Continue reading

Jan 31 2025

Pennsylvania House Majority Leader Sees “Path Forward On Cannabis”

Pennsylvania Governor Josh Shapiro is set to include marijuana legalization in his upcoming budget request, marking the third consecutive year he has advocated for the reform, with House Leader Matt Bradford (D) saying he sees “a path forward”.

Next week, Governor Shapiro is set to release his proposed 2025-2026 budget, which he has promised will include the legalization of recreational marijuana. House Majority Leader Matt Bradford (D) has expressed confidence that legalization could move forward this session, after years of attempts from proponents.

“Yes, our numbers are close, but we are confident that we can get our numbers together and show that there is a path forward on cannabis,” says Bradford.
Continue reading

Jan 31 2025

Virginia Senate Passes Bill to Legalize Recreational Marijuana Sales

Virginia has approved legislation that would legalize recreational marijuana.

By a vote of 21 to 19, the Senate advanced Senate Bill 970 to the state’s House of Representatives. Approval through the House would send the measure to Governor Glenn Youngkin, who has promised to veto the bill. The legislature can override a veto, but only with a 2/3rds majority.

Sponsored by State Senators Aaron Rouse (D), Jennifer Carroll Foy (D), and Lashrecse Aird (D), Senate Bill 970 would establish a retail marijuana market in Virginia, which remains the only one of the 24 states with legal marijuana to prohibit retail sales.
Continue reading

Jan 31 2025

Psilocybin Shows Strongest Evidence for Treating Alcohol Use Disorder in Psychedelic Therapy Review

A new systematic review highlights the potential of psychedelic-assisted therapy for substance use disorders, finding psilocybin to be the most promising treatment for alcohol use disorder (AUD).

Psilocybin mushroom.

Researchers from King’s College London, the University of Birmingham, and the South London and Maudsley NHS Foundation Trust reviewed 37 studies involving 2,035 participants, assessing treatments with LSD, mescaline, psilocybin, ayahuasca, ketamine, ibogaine, and MDMA.

According to the study, published in the journal Addiction, “A two-centre, placebo-controlled, phase 2 superiority RCT of psilocybin for AUD, and a two-centre, double-blind, four-arm, placebo-controlled phase 2 RCT of ketamine for AUD yielded the best evidence of efficacy.”
Continue reading

Jan 30 2025

New Mexico Bill Would Restrict Workplace Cannabis Testing for Medical Marijuana Patients

A bill to prohibit employers from considering an employee impaired based solely on the presence of cannabis metabolites in their system has been filed in New Mexico.

House Bill 230, introduced today by Representatives Reena Szczepanski (D) and Elizabeth Thomson (D), has been assigned to the House Health & Human Services Committee.

The proposal bans random drug testing for marijuana, allowing testing only in cases where an employer has reasonable suspicion of impairment while on the job or after an accident involving another person or significant property damage. Any positive test for marijuana would need to be reviewed by a medical review officer to determine if there is a legitimate medical explanation.
Continue reading

Jan 30 2025

New York Bill to Legalize Medical Psilocybin Filed Today, Companion Measure Already Filed in Senate

A bill to legalize the medical use of psilocybin in New York was introduced today by Assemblymember Patrick Burke (D) and referred to the Assembly Health Committee.

The measure, Assembly Bill 3775, serves as a companion to Senate Bill 495, which was filed on January 8 and sent to the Senate Finance Committee.

The legislation would create a framework for the medical use of psilocybin, allowing patients to receive supervised treatment under the guidance of certified facilitators, including mental health professionals, physicians, and other qualified practitioners. The bill outlines licensing requirements, research initiatives, and legal protections for patients and facilitators participating in the program.
Continue reading

Jan 30 2025

New Mexico Lawmakers Introduce Bipartisan Bill to Establish Medical Psilocybin Program

Legislation to create a program for the medicinal use of psilocybin was introduced today in the New Mexico Senate.

Dried psilocybin mushrooms.

Senate Bill 219, the Medical Psilocybin Act, would allow those in New Mexico to receive psilocybin-assisted treatment for certain behavioral health conditions, including major treatment-resistant depression, post-traumatic stress disorder, substance use disorders, end-of-life care, and other conditions approved by the Department of Health.

“When we’re facing epidemic levels of depression, anxiety, PTSD, and other debilitating mental health conditions, we owe it to those suffering to explore promising new treatments like psilocybin,” says State Representative Elizabeth Thomson (D). “By establishing a highly regulated, state-run program, we can provide alternative options to those not responding to traditional treatment, in a safe, controlled environment.”
Continue reading

Jan 30 2025

Study: Opening Recreational Marijuana Stores Has No Impact on Emergency Room Visits

A study being published soon by the International Journal of Drug Policy, published online ahead of print by the U.S. National Library of Medicine, analyzes the impact of recreational marijuana retailer allocation on emergency department visits in Ontario.

(Photo credit: Pablohart / Getty Images).

Researchers from York University, Western University, and the University of Toronto conducted a longitudinal study using health administrative data from ICES (a nonprofit research institute), covering all Ontario residents with public health insurance.

The study examined 278 communities, using Forward Sortation Areas (FSAs) as a proxy, and tracked 11,156,100 adults aged 18 and older from January 2016 to March 2023. The randomized lottery system used to allocate marijuana retailers provided a natural experiment, allowing for a comparison of emergency department visits in FSAs with and without retail stores.
Continue reading